EMV Capital
Early-stage, IP-rich companies in life sciences, deep tech and sustainability
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed, Series A, Series B+
- Sector focus
- Biotech & Life Sciences, Climate & Energy, Hardware & Robotics
- Cheque size
- €1.5M–€3M
- Fund size
- Undisclosed
- Website
- emvcapital.com
EMV Capital, formerly NetScientific PLC, is a London-listed venture investment group backing early-stage companies built on strong intellectual property. Its three areas are life sciences, deep tech (industrial technology, robotics and AI) and sustainability, including renewable energy, resource efficiency and waste reduction.
It combines balance-sheet investment with syndicated co-investment from third parties, and typically takes board seats. Support covers fundraising, IP strategy and executive hiring. Portfolio companies include PDS Biotechnology, Q-Bot, Xampla and Wanda Health. The firm is based in Mayfair, London.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.